< Back to latest news & events

UPC

Green Light from AG Bot for Unitary Patent in Europe

November 2014

The Opinion of Advocate General Bot, regarding Spain’s actions (CJEU cases C-146/13 and C-147/13) that the Regulations surrounding the creating of the European Unitary Patent should be annulled, has been given today. It is the Opinion of AG Bot that the CJEU should dismiss Spain’s actions.

Spain pleaded that the proposed language scheme would be discriminatory to persons whose mother tongue was not German, French or English. Furthermore, that aspects of EU law had been breached in the arranging of the Regulation on the Unitary Patent and Unified Patent Court.

Today’s press release states that unitary protection “brings real benefit” over the current European Patent Convention, where the effects of European patents are determined by national laws. Furthermore, even though the language arrangements that have been selected under the regime may curtail the use of some European languages, they “pursue a legitimate objective of reducing translation costs”. To limit the number of languages for the European Unitary Patent will reduce costs, and furthermore, acknowledges the linguistic realities of the patent sector (German, French and English are the most popular spoken languages from which patent application in the EU originate, as well as the languages of most published scientific papers).

In both cases brought by Spain, AG Bot proposed that CJEU should dismiss Spain’s actions.

The opinion of the Advocate General is not binding on the CJEU, and judgements will be given at a later stage. However, it is unusual for the Court not to follow the Opinion of the AG. The Opinion signifies a green light for unitary patent protection in Europe.

Latest updates

HGF ranked band 1 in Chambers and Partners UK 2025

Chambers and Partners UK 2025 guide is now live. HGF is proud to be highly ranked as a firm and to have five ranked individuals. HGF is ranked band 1 …

Read article

The EPO Looks at the Morality and Patentability of Therapeutics Derived from Traditional Knowledge

This case (T2510/181) heard before the Technical Boards of Appeal at the EPO in May 2024 relates to the morality and novelty of substances of a natural origin. The invention …

Read article
Event - 7th November 2024

CIPSC Corporate IP Strategy Conference

HGF are proud to be platinum sponsors of the CIPSC event in Santa Clara, US. The CIPSC Unified Patents event will be held in Santa Clara, US on Thursday 7th …

Event details
Event - 7th November 2024

OUI Annual Networking Event

HGF are proud to be sponsoring the OUI Annual Networking Event in London on Thursday 7th November. This event will host key discussions around the impact of the Oxford’s Innovation …

Event details

Bite-sized MBA Course

HGF are proud to announce 14 of our colleagues have completed a bite-sized MBA and have now achieved a strategy consultation accreditation awarded from The University of East Anglia. The …

Read article
Event - 24th October 2024

CTA Demo Day

HGF is proud to be speaking at the Cancer Tech Accelerator Demo Day 2024. The Cancer Tech Accelerator Day 2024 will be held at HGF Limited, Leeds on Thursday 24th …

Event details